---
figid: PMC7240957__metabolites-10-00169-g008
figlink: pmc/articles/PMC7240957/figure/metabolites-10-00169-f008/
number: Figure 8
caption: Potential mechanism of cytochrome P450 (CYP450)-dependent metabolism of polyunsaturated
  omega-6 and omega-3 fatty acids involved in CKD progression. (a) omega-6 PUFA pathway,
  (b) omega-3 PUFA pathway. Decreased mRNA expression of CYP2C23 and CYP2E1 prevent
  the production of EETs, as a vasodilator, from arachidonic acid. Increased mRNA
  expression of CYP2J4 induces the generation of EpOME and the corresponding DiHOME
  as a protoxin via the soluble epoxide hydrolase, leading to the progression of CKD.
  Metabolites in the red colored squares are increased. mRNA is increased in the red
  line circle and decreased in the blue line circle. CKD, chronic kidney disease;
  COX, cyclooxygenase; DHET, dihydroxyeicosatrienoic acid; DiHETE, dihydroxyeicosatetraenoic
  acid; DiHOME, dihydroxyoctadecenoic acid; EETs, epoxyeicosatrienoic acids; EPA,
  eicosapentaenoic acid; Ephx2, epoxide hydrolase 2; Ephx3, epoxide hydrolase 3; EpOME,
  epoxyoctadecenoic acid; EpETE, epoxyeicosatetraenoic acid; HETE, hydroxyeicosatetraenoic
  acid; LOX, lipoxygenase; PUFA, polyunsaturated fatty acid.
pmcid: PMC7240957
papertitle: 'Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers:
  A Metabolomic Analysis of Experimental Glomerulonephritis.'
reftext: Kyoung Hee Han, et al. Metabolites. 2020 Apr;10(4):169.
pmc_ranked_result_index: '57640'
pathway_score: 0.8861273
filename: metabolites-10-00169-g008.jpg
figtitle: Mechanism of cytochrome P450 (CYP450)-dependent metabolism of polyunsaturated
  omega-6 and omega-3 fatty acids involved in CKD progression
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7240957__metabolites-10-00169-g008.html
  '@type': Dataset
  description: Potential mechanism of cytochrome P450 (CYP450)-dependent metabolism
    of polyunsaturated omega-6 and omega-3 fatty acids involved in CKD progression.
    (a) omega-6 PUFA pathway, (b) omega-3 PUFA pathway. Decreased mRNA expression
    of CYP2C23 and CYP2E1 prevent the production of EETs, as a vasodilator, from arachidonic
    acid. Increased mRNA expression of CYP2J4 induces the generation of EpOME and
    the corresponding DiHOME as a protoxin via the soluble epoxide hydrolase, leading
    to the progression of CKD. Metabolites in the red colored squares are increased.
    mRNA is increased in the red line circle and decreased in the blue line circle.
    CKD, chronic kidney disease; COX, cyclooxygenase; DHET, dihydroxyeicosatrienoic
    acid; DiHETE, dihydroxyeicosatetraenoic acid; DiHOME, dihydroxyoctadecenoic acid;
    EETs, epoxyeicosatrienoic acids; EPA, eicosapentaenoic acid; Ephx2, epoxide hydrolase
    2; Ephx3, epoxide hydrolase 3; EpOME, epoxyoctadecenoic acid; EpETE, epoxyeicosatetraenoic
    acid; HETE, hydroxyeicosatetraenoic acid; LOX, lipoxygenase; PUFA, polyunsaturated
    fatty acid.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP2E1
  - COX4I1
  - COX6A1
  - COX6A2
  - COX6B1
  - COX7A1
  - COX7A2
  - COX8A
  - COX10
  - COX11
  - COX5A
  - COX17
  - COX4I2
  - COX8C
  - COX5B
  - COX7B
  - COX15
  - COX6B2
  - COX7B2
  - EPHX3
  - EPHX2
genes:
- word: CYP2E1
  symbol: CYP2E1
  source: hgnc_symbol
  hgnc_symbol: CYP2E1
  entrez: '1571'
- word: CYP2E1)
  symbol: CYP2E1
  source: hgnc_symbol
  hgnc_symbol: CYP2E1
  entrez: '1571'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A1
  entrez: '1337'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A2
  entrez: '1339'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B1
  entrez: '1340'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A1
  entrez: '1346'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A2
  entrez: '1347'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8A
  entrez: '1351'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX10
  entrez: '1352'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX11
  entrez: '1353'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5A
  entrez: '9377'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX17
  entrez: '10063'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I2
  entrez: '84701'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8C
  entrez: '341947'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5B
  entrez: '1329'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B
  entrez: '1349'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX15
  entrez: '1355'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B2
  entrez: '125965'
- word: cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B2
  entrez: '170712'
- word: Ephx3
  symbol: EPHX3
  source: hgnc_symbol
  hgnc_symbol: EPHX3
  entrez: '79852'
- word: Ephx2
  symbol: EPHX2
  source: hgnc_symbol
  hgnc_symbol: EPHX2
  entrez: '2053'
chemicals: []
diseases: []
---
